MICHELLE GAHGAN: Open Payments
NPI 1497373286 · ALGONQUIN, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,959 in 179 payments from 24 companies in 2025. Trend: 2023 $3,008 · 2024 $3,755 · 2025 $3,959
Food & beverage: $3,959
| Company | Payments | Amount |
|---|---|---|
| Corcept Therapeutics | 12 | $409 |
| ABBVIE INC. | 18 | $369 |
| Novo Nordisk Inc | 14 | $350 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 13 | $316 |
| PFIZER INC. | 16 | $295 |
| AstraZeneca Pharmaceuticals LP | 14 | $272 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 12 | $264 |
| Lilly USA, LLC | 10 | $222 |
| Lundbeck LLC | 10 | $196 |
| Paratek Pharmaceuticals, Inc. | 7 | $182 |
Products named: Korlym, JARDIANCE, REXULTI, CAPLYTA, VRAYLAR, NUZYRA, SPRAVATO, FARXIGA.
Industry payments across IL — which companies pay providers there.
